Back

Learned Immune Architectures of Durable Antibody Responses Across Vaccines

Hao, S. P.; Tomic, I.; Tomic, A.; Przytycki, P. F.

2026-07-13 immunology
10.64898/2026.07.08.737303 bioRxiv
Show abstract

Vaccination is one of the most effective public health interventions. However, vaccine efficacy varies widely among individuals, as immunity arises from complex interplay between genetic, pathogen, and immunological factors. To date, most systems vaccinology studies have remained pathogen-specific, precluding the discovery of potential shared immune architectures underlying durable antibody responses. To address this gap, we leveraged transcriptomic data from 1,032 participants receiving influenza, hepatitis B, or yellow fever vaccines to develop an interpretable machine learning framework for comparative analysis across diverse vaccine platforms. Pathogen-specific models using Blood Transcriptional Module-based feature aggregation accurately predicted high antibody responders and consistently outperformed gene-level models. Distinct predictive immune architectures identified across vaccines were further resolved for dominant hierarchical immune programs using surrogate decision trees. This approach identified the dominant decision boundaries underlying each vaccine model, highlighting leukocyte migration and Th2 differentiation in Hepatitis B, CD4+ T cells, M2 macrophages, and c-MYC signaling in Influenza, and B-cell receptor signaling with B-cell developmental pathways in Yellow Fever. Cross-pathogen concordance analyses further identified four shared transcriptional modules, suggesting partially conserved immune architectures across diverse vaccines. Together, these findings provide new insights into the immune mechanistic underpinnings of durable vaccine responses across vaccines and provide an interpretable framework for comparative systems vaccinology that may guide the rational design of next-generation vaccines. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=77 SRC="FIGDIR/small/737303v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@1b5be56org.highwire.dtl.DTLVardef@e323dborg.highwire.dtl.DTLVardef@470eb4org.highwire.dtl.DTLVardef@116759f_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Cell Reports
1498 papers in training set
Top 1%
11.8%
2
Frontiers in Immunology
638 papers in training set
Top 1%
9.6%
3
Nature Communications
5641 papers in training set
Top 22%
7.2%
4
npj Vaccines
67 papers in training set
Top 0.2%
5.4%
5
Nature Immunology
79 papers in training set
Top 0.5%
5.4%
6
eLife
5828 papers in training set
Top 22%
5.4%
7
iScience
1154 papers in training set
Top 6%
3.4%
8
Science Advances
1243 papers in training set
Top 10%
3.2%
50% of probability mass above
9
Cancer Cell
42 papers in training set
Top 0.5%
2.7%
10
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 0.8%
2.6%
11
PLOS Computational Biology
1863 papers in training set
Top 11%
2.6%
12
PLOS Pathogens
820 papers in training set
Top 5%
2.4%
13
Nature Medicine
125 papers in training set
Top 1%
2.4%
14
Immunity
67 papers in training set
Top 0.8%
2.4%
15
Cell Reports Medicine
153 papers in training set
Top 2%
2.1%
16
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 24%
2.1%
17
Cell Discovery
57 papers in training set
Top 0.5%
1.9%
18
Cell
431 papers in training set
Top 6%
1.7%
19
Advanced Science
286 papers in training set
Top 5%
1.7%
20
eBioMedicine
183 papers in training set
Top 3%
1.7%
21
mBio
833 papers in training set
Top 9%
1.1%
22
Cell Systems
201 papers in training set
Top 4%
1.1%
23
Cancer Immunology Research
35 papers in training set
Top 0.7%
1.0%
24
Cell Research
51 papers in training set
Top 1%
0.8%
25
Vaccine
203 papers in training set
Top 2%
0.8%
26
Scientific Reports
3612 papers in training set
Top 75%
0.8%
27
Science
477 papers in training set
Top 9%
0.8%
28
PLOS ONE
5266 papers in training set
Top 65%
0.6%
29
Journal of Virology
499 papers in training set
Top 4%
0.6%
30
Science Immunology
88 papers in training set
Top 2%
0.6%